This post was originally published on this site
https://i-invdn-com.akamaized.net/news/LYNXMPEB280W7_M.jpg
The company reiterated that it had not received a warning letter from the U.S. Food and Drugs Administration following inspections at the plant first revealed by Reuters last week.
The company, however, also reiterated that it had received an Official Action Indicated (OAI) notice from the FDA in relation to issues at its Branchburg plant in New Jersey.
